Gastroenterology 146 , 652660.e1 (2014)
Concurrently, glucagon-like peptide-1 (GLP-1) receptor agonists like Ozepmic, Tirzepatide, and a litany of others, have emerged as effective treatments for obesity and type 2 diabetes
For that reason, any decision to pause or stop GLP-1 therapy should always be made in consultation with a qualified healthcare provider who can document the plan, adjust dosing, and help protect continued coverage
By April, Roberts had moved to an apartment in Cumberland, got custody of her son, earned her CNA license and was preparing to reenter the work force
10.1016/j.neuroscience.2014.11.025 26